期刊文献+

原发性醛固酮增多症在中国的诊治现状及研究进展 被引量:9

Diagnosis, treatment and progress of primary aldosteronism in China
原文传递
导出
摘要 原发性醛固酮增多症(原醛症)是导致继发性高血压的一个重要原因,在高血压人群中患病率约为10%~20%,与原发性高血压患者相比,原醛症患者心脑等高血压靶器官损害更为严重.本文将从原醛症患病率、筛查、确诊、分型、治疗及基础研究等方面进行探讨,进一步阐述中国原醛症的发展与现状. Primary aldosteronism is an important cause of secondary hypertension with the prevalence of 10%-20%in hypertensive patients. Compared with essential hypertension, primary aldosteronism patients have more cardiovascular and cerebrovascular complications. In this article, we will make a discussion on the development and current situation of primary aldosteronism by means of its prevalence, case detection, case confirmation, subtype classification, treatment and basic research.
作者 蒋怡然 王卫庆 Jiang Yiran, Wang Weiqing(Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2018年第9期717-720,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 原发性醛固酮增多症 醛固酮/肾素活性比值 生理盐水试验 卡托普利试验 双侧肾上腺静脉采血 螺内酯 KCNJ5基因 Primary aldosteronism Ratio of aldosterone to plasma renin activity Saline infusion test Captopril challenge test Bilateral adrenal venous sampling Spironolactone KCNJ5 gene
  • 相关文献

参考文献9

二级参考文献78

共引文献267

同被引文献58

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部